Intermittent Vismodegib Therapy in Basal Cell Nevus Syndrome

JAMA Dermatol. 2016 Feb;152(2):223-4. doi: 10.1001/jamadermatol.2015.3210.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anilides / administration & dosage*
  • Anilides / adverse effects
  • Anilides / agonists
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Basal Cell Nevus Syndrome / drug therapy*
  • Basal Cell Nevus Syndrome / pathology
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pyridines / administration & dosage*
  • Pyridines / adverse effects
  • Pyridines / agonists
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology
  • Treatment Outcome

Substances

  • Anilides
  • Antineoplastic Agents
  • HhAntag691
  • Pyridines